VEGF promotes angiogenesis and matrix metalloproteinases exacerbate inflammation and exudation, while interleukin-18 damages the function of NK cells and T cells, thereby impairing the host's immune response to tumor antigens (22–24). This evidence concerns the gene VEGFA and neoplasm.